The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C

Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C

May 13, 2016 • By Catherine Kolonko

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The 30% rise in the number of joint replacements among patients with hepatitis C was not merely a reflection of a general upswing over the years in these types of operations, says Dr. Mont. Taking into account the number of operations among the general population, the frequency of hepatitis C infection rose from 1.9 per 1,000 total joint arthroplasties in 1998 to 5.9 per 1,000 total joint arthroplasties in 2010.

You Might Also Like
  • Predictors of RA Flare After Total Joint Arthroplasty
  • Total Joint Arthroplasty Outcome Measures Toolkit Helps Rheumatologists’ Post-Surgical Assessments
  • Minimally Invasive Total Hip Arthroplasty Audioconference
Explore This Issue
May 2016

Previous Studies

Earlier studies that were smaller and conducted at single centers have shown similar findings, Dr. Mont explains. So even though results of the most recent study were somewhat expected, they do help further clarify some concerns facing patients with hepatitis C who have compromised immune systems and may be more susceptible to infection if they undergo surgery, he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Orthopedic surgeons should be aware of the increased risks of total joint arthroplasty in patients with hepatitis C & should discuss these risks with potential surgical candidates during a shared decision-making process.

“It’s just defining it a little bit better,” Dr. Mont explains. “We would expect that people who have had hepatitis are going to be more immunocompromised, more subject to vasculitis” and more subject to adverse effects on all of their organ systems, he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Future studies are needed to determine whether adopting strict measures to optimize the medical health of a patient infected with hepatitis C could lead to reduced complications from hip or knee arthroplasty, Dr. Mont says.

Conclusions

The authors concluded that hepatitis C infection is an infrequent but increasingly common co-morbidity among patients who undergo total joint arthroplasty.

“Given these findings, orthopaedic surgeons should be aware of the increased risks of total joint arthroplasty in patients with hepatitis C and should discuss these risks with potential surgical candidates during a shared decision-making process,” the authors write in the study.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Insight gained from the study is useful in the counseling of patients with hepatitis C about their increased risks when considering a total joint arthroplasty procedure, according to the authors of a separate commentary that appears in the same journal issue as the study article.2

“An awareness of the need for and benefit of patient education, medical optimization and utilization of a medical or surgical care team approach could help to decrease the complication rate associated with total joint arthroplasty in this population,” write Pooya Javidan, MD, and Richard H. Walker, MD, of the Scripps Clinic in La Jolla, Calif.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Guidelines Tagged With: hepatitis C, Outcomes, patient care, risk, total join arthroplastyIssue: May 2016

You Might Also Like:
  • Predictors of RA Flare After Total Joint Arthroplasty
  • Total Joint Arthroplasty Outcome Measures Toolkit Helps Rheumatologists’ Post-Surgical Assessments
  • Minimally Invasive Total Hip Arthroplasty Audioconference
  • Liposomal Bupivacaine Helpful in Total Knee Arthroplasty

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)